J.P. Morgan·2026-07-31SectorChina Insurance 1H26 Preview: Dividend surprise could reset the trade; Ping An-H top pickChina insurance·Overweight
J.P. Morgan·2026-07-31SectorChina Solar 2H26: Sequential improvement while valuations are at trough; u g XYS, Flat to OW and LONGi, SZ SC to NChina solar·Overweight
J.P. Morgan·2026-07-30MacroFX FOMC post-mortem: Staying long-USD despite renewed inflation risk premium
J.P. Morgan·2026-07-30StrategyChina Equity Strategy: AI entry point improving, balanced by shareholder return playsChina AI·Overweight
J.P. Morgan·2026-07-30CreditJPM HY HC: 2Q26 CRO, Pharma Services Earnings Observations: IQV, FTRE, and AVTR Earnings Review
J.P. Morgan·2026-07-30StrategyAsia Pacific Equity Derivatives Strategy: Japan Thematic Rotation Trades Amid Yen Reversal Risk; Diversify into Korea Buybacks Amid AI Momentum Unwind
J.P. Morgan·2026-07-30SectorElectronic Components Sector : MLCC eXchange: June 2026 trade data; will this be a summer of price hikes?MLCC·Overweight
J.P. Morgan·2026-07-30SectorPCs and Servers: Read-through from Microsoft Meta Jun-26 earningsServer ODMs·Overweight
J.P. Morgan·2026-07-30SectorSemiconductor SPE Implications from Teradyne’s results: Progress in achieving second-vendor status with hyperscaler
J.P. Morgan·2026-07-29CreditVertiv (VRT.US) Positive 2Q26 Results; Data Center Spending Supports Another FY26 Guidance RaiseVRT
J.P. Morgan·2026-07-29SectorAsia Power Equipment: Implications of 800V DC Data Center Architecture. Call Series Takeaways
J.P. Morgan·2026-07-29SectorAsia Insurance Summer Series: Leverage in insurance; attractive ROE, but no free lunch
J.P. Morgan·2026-07-29SectorChina Healthcare GSK and AZ 2Q26 results: Read-through to Hansoh, Hengrui and Kelun Biotech
J.P. Morgan·2026-07-28SectorProperty Data Monitor Mainland China: Primary sales +8% Y Y month-to-date; HK: strong sell-through rates in new launches, but valuation index softened